Leptin protects placental cells from apoptosis induced by acidic stress.


Journal

Cell and tissue research
ISSN: 1432-0878
Titre abrégé: Cell Tissue Res
Pays: Germany
ID NLM: 0417625

Informations de publication

Date de publication:
Mar 2019
Historique:
received: 21 05 2018
accepted: 25 09 2018
pubmed: 20 10 2018
medline: 1 6 2019
entrez: 20 10 2018
Statut: ppublish

Résumé

Development of the human placenta is critical for a successful pregnancy. The placenta allows the exchange of oxygen and carbon dioxide and is crucial to manage acid-base balance within a narrow pH. It is known that low pH levels are a risk of apoptosis in several tissues. However, there has been little discussion about the effect of acidic stress in the placenta. Leptin is produced by the placenta with a trophic autocrine effect. Previous results of our group have demonstrated that leptin prevents apoptosis of trophoblast cells under different stress conditions such as serum deprivation and hyperthermia. The purpose of the present work is to evaluate acidic stress consequences in trophoblast explant survival and to determine leptin action in these conditions. For this objective, term human trophoblast explants were cultured at physiological pH (pH 7.4) and at acidic pH (pH 6.8) in the presence or absence of leptin. Western blot assays were performed to study the abundance of active caspase-3 and the p89 fragment of PARP-1. Pro-apoptotic and pro-survival members of Bcl-2 family, as Bax, t-Bid, and Bcl-2, were studied. Moreover, p53 pathway was also evaluated including Mdm-2, the main p53 regulator. Active caspase-3 and cleaved PARP-1 abundances were increased at low extracellular pH. Moreover, t-Bid levels were also augmented as well as p53 expression and phosphorylation on S46. Leptin treatment prevents the consequences of acidosis, decreasing p53 expression and increasing Mdm-2 expression. In summary, this work demonstrated for first time that low pH induces apoptosis of human trophoblast explants involving apoptotic intrinsic pathway, and leptin impairs this effect.

Identifiants

pubmed: 30338379
doi: 10.1007/s00441-018-2940-9
pii: 10.1007/s00441-018-2940-9
doi:

Substances chimiques

Acids 0
BH3 Interacting Domain Death Agonist Protein 0
Leptin 0
Tumor Suppressor Protein p53 0
bcl-2-Associated X Protein 0
Proto-Oncogene Proteins c-mdm2 EC 2.3.2.27

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

733-742

Subventions

Organisme : Instituto de Salud Carlos III
ID : PS09/00119 and PI12/01172, funded in part by FEDER

Auteurs

Antonio Pérez-Pérez (A)

Department of Medical Biochemistry and Molecular Biology and Immunology, School of Medicine, Virgen Macarena University Hospital, University of Seville, Av. Dr. Fedriani 3, 41071, Seville, Spain.

Ayelén Toro (A)

Laboratory of Placental Molecular Physiology, Department of Biological Chemistry, School of Sciences, University of Buenos Aires, IQUIBICEN-CONICET, Ciudad Universitaria, Pab. 2, Buenos Aires, Argentina.

Teresa Vilariño-Garcia (T)

Department of Medical Biochemistry and Molecular Biology and Immunology, School of Medicine, Virgen Macarena University Hospital, University of Seville, Av. Dr. Fedriani 3, 41071, Seville, Spain.

Pilar Guadix (P)

Department of Obstetrics and gynecology, Virgen Macarena University Hospital, University of Seville, Seville, Spain.

Julieta Maymó (J)

Laboratory of Placental Molecular Physiology, Department of Biological Chemistry, School of Sciences, University of Buenos Aires, IQUIBICEN-CONICET, Ciudad Universitaria, Pab. 2, Buenos Aires, Argentina.

José Luis Dueñas (JL)

Department of Obstetrics and gynecology, Virgen Macarena University Hospital, University of Seville, Seville, Spain.

Cecilia Varone (C)

Laboratory of Placental Molecular Physiology, Department of Biological Chemistry, School of Sciences, University of Buenos Aires, IQUIBICEN-CONICET, Ciudad Universitaria, Pab. 2, Buenos Aires, Argentina.

Víctor Sánchez-Margalet (V)

Department of Medical Biochemistry and Molecular Biology and Immunology, School of Medicine, Virgen Macarena University Hospital, University of Seville, Av. Dr. Fedriani 3, 41071, Seville, Spain. margalet@us.es.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH